@article{ade17fb7d2dd4372b12b81fa98170f22,
title = "Pharmacotherapy of aggression in a 9-year-old with ADHD",
author = "Findling, {Robert L.} and Newcorn, {Jeffrey H.} and Malone, {Richard P.} and Ayesha Waheed and Prince, {Jefferson B.} and Kratochvil, {Christopher J.}",
note = "Funding Information: Disclosure: Dr. Findling receives or has received research support from, acted as a consultant to, or served on a speakers' bureau of Abbott, AstraZeneca, Bristol-Myers Squibb, Celltech-Medeva, Forest, GlaxoSmithKline, Johnson & Johnson, Lilly, New River, Novartis, Otsuka, Pfizer, Shire, Sanofi-Aventis, Solvay, and Wyeth. Dr. Malone has received investigator-initiated funding from Eli Lilly, Pfizer, and Bristol-Myers Squibb and served as a consultant to Eli Lilly. Dr. Prince is a member of the speakers' bureaus of McNeil and Janssen; has received honoraria from Shire, Novartis, and Cephalon; and has been a consultant to Shire, Novartis, Cephalon, and McNeil. Dr. Kratochvil has received grant support from, is a consultant to, and/or member of the speakers' bureaus of Eli Lilly, GlaxoSmithKline, Forest, Shire, Cephalon, Novartis, McNeil, Organon, AstraZeneca, and Pfizer. Dr. Newcorn receives research support from McNeil Pediatrics and Eli Lilly and is a consultant to, advisor to, or speaker for McNeil Pediatrics, Shire, Novartis, Eli Lilly, Cephalon, Cortex, and Pfizer. Dr. Waheed has no financial relationships to disclose. ",
year = "2007",
month = may,
doi = "10.1097/chi.0b013e3180335b4a",
language = "English (US)",
volume = "46",
pages = "653--658",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Inc.",
number = "5",
}